Document is current
Any future updates will be listed below
-
Authors
Yagiz, Burcu https://orcid.org/0000-0002-0624-1986
Coskun, Belkis Nihan https://orcid.org/0000-0003-0298-4157
Pehlivan, Yavuz https://orcid.org/0000-0002-7054-5351
Dalkilic, Ediz https://orcid.org/0000-0001-8645-2670
Kiraz, Sedat https://orcid.org/0000-0003-2802-6061
Yazisiz, Veli https://orcid.org/0000-0002-3176-4850
Kucuksahin, Orhan https://orcid.org/0000-0001-6577-8129
Erden, Abdulsamet https://orcid.org/0000-0002-8084-2018
Kanitez, Nilufer Alpay https://orcid.org/0000-0003-1185-5816
Kimyon, Gezmiş https://orcid.org/0000-0003-3775-639X
Emmungil, Hakan https://orcid.org/0000-0001-5184-4404
Bilge, Sule Yasar https://orcid.org/0000-0002-0783-1072
Kasifoglu, Timucin https://orcid.org/0000-0003-2544-8648
Bes, Cemal https://orcid.org/0000-0002-1730-2991
Bolek, Ertugrul Cagri https://orcid.org/0000-0003-3886-2813
Bilgin, Emre https://orcid.org/0000-0002-2260-4660
Karatas, Ahmet https://orcid.org/0000-0002-6725-4182
Kelesoglu, Bahar https://orcid.org/0000-0001-8810-2869
Ersozlu, Duygu https://orcid.org/0000-0001-6172-7762
Gonullu, Emel Orge https://orcid.org/0000-0002-6990-4206
Mercan, Ridvan https://orcid.org/0000-0003-1537-2192
Yilmaz, Sedat https://orcid.org/0000-0002-4691-3417
Karadag, Omer https://orcid.org/0000-0002-3443-3117
Akar, Servet https://orcid.org/0000-0002-3734-1242
Ertenli, Ihsan https://orcid.org/0000-0002-3904-0769
Kalyoncu, Umut https://orcid.org/0000-0001-7129-2109
-
Funding
Funding for this research was provided by:
Hacettepe Üniversitesi
- License Information
-
More Information
Article History
Received: 3 May 2021
Accepted: 28 June 2021
First Online: 5 July 2021
Declarations
:
: UK received honorary from Abbvie, Amgen, Johnson and Johnson, MSD, Novartis, Pfizer, Roche, UCB. YP received honorary from Abbvie, Roche, Novartis, MSD, Pfizer. TK received honorary from Abbvie, Amgen, MSD, Novartis, Pfizer, Roche, UCB. GK received honorary from Abbvie, Amgen, Novartis, Pfizer, UCB. OK received honorary from Amgen, Johnson and Johnson, MSD, Novartis, Pfizer, Roche, UCB. ED received honorary from Abbvie, Amgen, Johnson and Johnson, MSD, Novartis, Pfizer, Roche, UCB. IE received honorary from Abbvie, Amgen, Johnson and Johnson, MSD, Novartis, Pfizer, Roche, UCB. SK received honorary from Abbvie, Amgen, MSD, Novartis, Pfizer, Roche, UCB. DE received honorary from Abbvie, Amgen, MSD, Novartis, Pfizer, UCB. CB received honorary from Abbvie, Amgen, MSD, Novartis, Pfizer, Roche, UCB. HE received honorary from Novartis, Roche. RM received honorary from Abbvie, Amgen, MSD, Novartis, Pfizer, Roche, UCB. NK received honorary from Novartis, UCB. SY received honorary from Abbvie, Amgen, Johnson and Johnson, MSD, Novartis, Pfizer, Roche, UCB. Other authors declare no conflict of interest.
: To perform the present research, the approval for the TReasure database was obtained from the Ethics Committee of Hacettepe University in May 2017 (KA17/058) and from the Republic of Turkey Ministry of Health in October 2017 (93189304-14.03.01).
: Written informed consent of all patients was obtained.
: Not applicable.
